Vaccination With Peptides From Anti-apoptotic Proteins in Relapsed Multiple Myeloma
Clinical trial NCT01272466 · COMPLETED
Trial details
- NCT number
- NCT01272466
- Sponsor
- Herlev Hospital
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-01
- Primary completion
- 2012-02-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.